Rethinking the role of hydroxychloroquine in the treatment of COVID‐19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rethinking the role of hydroxychloroquine in the treatment of COVID‐19
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 34, Issue 5, Pages 6027-6037
Publisher
Wiley
Online
2020-04-30
DOI
10.1096/fj.202000919
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
- (2020) Stephen A. Lauer et al. ANNALS OF INTERNAL MEDICINE
- Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
- (2020) Hong-Yi Zheng et al. Cellular & Molecular Immunology
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- A Review of SARS-CoV-2 and the Ongoing Clinical Trials
- (2020) Yung-Fang Tu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COVID-19 spike-host cell receptor GRP78 binding site prediction
- (2020) Ibrahim M. Ibrahim et al. JOURNAL OF INFECTION
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
- (2020) Joseph T. Wu et al. NATURE MEDICINE
- Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
- (2020) Irani Thevarajan et al. NATURE MEDICINE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
- (2020) Philippe Gautret et al. Travel Medicine and Infectious Disease
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Tao Guo et al. JAMA Cardiology
- Estimates of the severity of coronavirus disease 2019: a model-based analysis
- (2020) Robert Verity et al. LANCET INFECTIOUS DISEASES
- Human Coronavirus: Host-Pathogen Interaction
- (2019) To Sing Fung et al. Annual Review of Microbiology
- Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus
- (2019) Leonid D. Zamora et al. International Journal of Rheumatic Diseases
- Transcription Factor T-bet in B Cells Modulates Germinal Center Polarization and Antibody Affinity Maturation in Response to Malaria
- (2019) Ann Ly et al. Cell Reports
- Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation
- (2018) Keagan P. Collins et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus
- (2018) Ji Yang et al. JOURNAL OF RHEUMATOLOGY
- MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells
- (2018) Yu Cong et al. PLoS One
- Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy
- (2018) Enric Mocholi et al. Cell Reports
- Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation
- (2016) Sera Oh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cutting Edge: Antimalarial Drugs Inhibit IFN-β Production through Blockade of Cyclic GMP-AMP Synthase–DNA Interaction
- (2015) Jie An et al. JOURNAL OF IMMUNOLOGY
- Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence
- (2015) L. Durcan et al. JOURNAL OF RHEUMATOLOGY
- Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
- (2015) K. D. Rainsford et al. INFLAMMOPHARMACOLOGY
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
- (2014) Adriaan H. de Wilde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection
- (2014) Kevin Maringer et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Effectiveness of Chloroquine and Inflammatory Cytokine Response in Patients With Early Persistent Musculoskeletal Pain and Arthritis Following Chikungunya Virus Infection
- (2013) Arvind Chopra et al. Arthritis & Rheumatology
- Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?
- (2012) E. F. Borba et al. RHEUMATOLOGY
- Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial
- (2011) Nicholas I Paton et al. LANCET INFECTIOUS DISEASES
- Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by Plasmodium vivax
- (2009) H.-S. Lim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Primary CD8+ T-Cell Response to Soluble Ovalbumin Is Improved by Chloroquine Treatment In Vivo
- (2008) B. Garulli et al. Clinical and Vaccine Immunology
- MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
- (2008) Timothy Sheahan et al. PLoS Pathogens
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started